Federal Circuit Affirms: Copaxone Patents Are Invalid As Obvious

WASHINGTON, D.C. —  A panel of the Federal Circuit U.S. Court of Appeals on Oct. 12 upheld findings by U.S. Judge Gregory M. Sleet of the District of Delaware that four...

Already a subscriber? Click here to view full article